Evidence against the presence of "inhibitors" in coumarin treated patients.
Coumarin drugs or vitamin K absence cause a decrease of factor II, VII, IX and X activities and the appearance of pre-factors into the circulation. Such pre-factors have been postulated to inhibit thrombin conversion. The current of research on the alleged activity of such "inhibitors" is taken into consideration. Thrombotest discrepancy, mixing experiments etc.) speak against the inhibitor theory. So far the only sure demonstration of the presence of coumarin induced pre-factors has been obtained by immunological means. However, this does not say anything about their biological activity. These pre-factors could well be "inert" as far as clotting is concerned. Until new, unequivocal data on the subject will be available, any method or technique claiming to be able to detect or monitor the "inhibitory" effect should be accepted with extreme caution. Too many unjustified views have been put forward in recent years.
D003374:Coumarins / Q000009:adverse effects*; D006801:Humans; D011516:Prothrombin / Q000037:antagonists & inhibitors*; D013917:Thrombin / Q000378:metabolism; D014813:Vitamin K Deficiency
D003374:Coumarins; D011516:Prothrombin; D013917:Thrombin